Development of effective, accessible rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes and improved disease management.
Our Diagnostic Products
COVID-19 PCR Diagnostic Kit
Launched in 2021, our rapid COVID-19 test is designed to provide results in less than 25 minutes. Compatible with both nasal and oral samples, our test can provide a more comfortable and less invasive point-of-care experience.
Peri-Implantitis Oral Biosensor
This affordable biosensor allows for early detection of infection associated with dental implants, preventing the progression of issues and improving treatment outcomes. Planned launch in late 2021.
H1N1 (Swine Flu) and H5N1 (Avian Flu) Oral Biosensors
This series of biosensors planned for launch in 2022 will help with early detection of highly pathogenic influenza A strains. They are administered via oral dissolvable films, releasing a bitter compound for positive results.
We’re striving for improved pandemic management.
With our COVID-19 diagnostics, we’re aiming to reduce the time people spend waiting for results and expedite the recovery of global industries.
Rapid Delivery and Production
We’re working with world-class industry & academic leaders in life science.
Be in the know. Get our press releases and latest news first.
Hear about our latest research, products, exclusive partnerships & more.